Skip to main content

Table 3 Change in hypertensive and diuretic medications during the 12-month study period

From: Agreement between cystatin-C and creatinine based eGFR estimates after a 12-month exercise intervention in patients with chronic kidney disease

Medication Control LI P value
Commenced Ceased Commenced Ceased
ACE inhibitor, n(%) + 1(1.5) −5(7.4) + 1(1.4) −7(9.5) 0.83
ATRB, n(%) + 4(5.9) − 2(2.9) +6(8.1) − 6(8.1) 0.30
Thiazide, n(%) + 1(1.5) −2(2.9) + 1(1.4) −3(4.1) 0.90
Spironolactone, n(%) 0 −2(2.9) 0 0  
Loop diuretics, n(%) +6(8.8) −3(4.4) + 4(5.4) −3(4.1) 0.76
  1. ACE angiotensin-converting-enzyme, ATRB angiotensin receptor blocker